GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › PDEX growth analysis
Growth stock analysis · updated 2026-07-27

Pro-Dex Inc New (PDEX) growth stock analysis

Is Pro-Dex Inc New a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Partly. PDEX is a mixed case
69
Growth score
87
RS rating
#601
Rank
3/6
Traits passed
69/99
Growth score · 601st of 4,897 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about PDEX

As of the 2026-07-27 close, PDEX scores 69 out of 99 on our growth-stock rating, a mixed growth-stock profile. That ranks it 601st of 4,897 rated US stocks, the top 12% of the market.

Its strongest trait is S (supply & demand) at 77, and its weakest is N (new highs & catalysts) at 0. PDEX clears 3 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, PDEX carries a strong Relative Strength rating of 87, meaning it has outperformed about 87% of the market over the past year.

Underneath the score: quarterly earnings up 22% year over year, sales up 15%, trading 15% below its 52-week high.

PDEX growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
65
A
Annual earnings growth
multi-year earnings trend
66
N
New highs & catalysts
proximity to new 52-week highs
0
S
Supply & demand
volume behind the move vs. share supply
77
L
Leader or laggard
Relative Strength within its group
60
I
Institutional sponsorship
fund accumulation and 13F ownership
43

Is PDEX a growth stock?

Partly. PDEX is a mixed case

PDEX passes some CANSLIM traits but not others. The letter breakdown above shows exactly where it holds up and where it falls short.

🔒 Stronger growth stocks than PDEX

The stocks ranking above PDEX today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 PDEX price history & buy range

Where PDEX sits in its base, its 52-week path, and the trait trend over the past year.

Open the full PDEX profile →

See where PDEX ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

PDEX as a growth stock, frequently asked

Is PDEX a good growth stock?

Partly. PDEX is a mixed case. PDEX passes some CANSLIM traits but not others. The letter breakdown above shows exactly where it holds up and where it falls short.

What is PDEX's growth score?

Pro-Dex Inc New (PDEX) scores 69 out of 99 on our growth-stock rating as of the 2026-07-27 close, ranking 601st of 4,897 rated US stocks.

Does PDEX have strong earnings growth?

PDEX's most recent quarterly earnings were up about 22% year over year, with sales up 15%.

How strong is PDEX's price performance?

PDEX has a Relative Strength rating of 87, meaning it has outperformed roughly 87% of the US market over the trailing year.

Where can I see PDEX's full analysis?

Create a free Growth Stock Analyzer account to see where PDEX ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Surgical & Medical Instruments & Apparatus